Hetzer Medical Indonesia Tbk. vs Paramita Bangun Sarana Tbk. — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp86 (market cap 139.06B, 51.66M 24h volume), while Paramita Bangun Sarana Tbk. trades at Rp750 (market cap 2.28T, 994K 24h volume). The key difference: Paramita Bangun Sarana Tbk. is far larger — about 16.4× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (51.66M versus 994K). Which is the better fit depends on your goals.
| MEDS | PBSA | |
|---|---|---|
Market Cap | 139.06B | 2.28T |
Volume | 51.66M | 994K |
Lot | 516.62K | 9.94K |
Turnover | 4.44B | 754.23M |
Average Price | 85.97 | 758.78 |
Value | 4.44B | 754.23M |
Indicative Equilibrium Price | 86 | 750 |
Indicative Equilibrium Volume | 9.62K | 56 |
Trailing returns across standard periods
Latest headlines on both assets
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →PT. Paramita Bangun Sarana Tbk (the Company) was established based on the Notarial Deed No. 33 of Lenny Janis Ishak, S.H., dated November 27, 2002.
Read more on PBSA →